FindTrial
Sign In

Ergocalciferol in Chronic Kidney Disease

The Effect of Ergocalciferol Treatment on 25-Hydroxyvitamin D Levels and Plasma Intact PTH in Patients With Chronic Kidney Disease Stage 3 and 4

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00411294
Enrollment
Unknown
Registered
2006-12-13
Start date
Unknown
Completion date
Unknown
Last updated
2006-12-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Kidney Disease

Keywords

ergocalciferol, chronic kidney disease, secondary hyperparathyroidism, vitamin D deficiency

Brief summary

To examine the effect of ergocalciferol treatment on 25-hydroxyvitamin D and PTH levels in patients with CKD stage 3 and 4

Interventions

None listed

Sponsors

Saint Louis VA Medical Center
Lead SponsorFED

Study design

Observational model
DEFINED_POPULATION
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Patient with CKD stage 3 or 4 whose 25-hydroxyvitamin D levels are below 30 ng/ml and plasma intact PTH levels \>70 pg/ml.

Exclusion criteria

* Patients who are on any form of active vitamin treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026